Effects of MDMA Co-administration on the Response to LSD in Healthy Subjects
Latest Information Update: 25 Aug 2022
At a glance
- Drugs Lysergide (Primary) ; Methylenedioxymetamfetamine (Primary)
- Indications Anxiety disorders; Cluster headache; Major depressive disorder; Pain
- Focus Adverse reactions; Pharmacodynamics
- Acronyms LSD-MDMA; MDMA-LSD
- 22 Aug 2022 Status changed from recruiting to completed.
- 06 Sep 2021 Planned End Date changed from 1 Jan 2022 to 30 Jun 2022.
- 06 Sep 2021 Planned primary completion date changed from 1 Jan 2022 to 30 Jun 2022.